关注
Bruce Sullenger
Bruce Sullenger
Duke University
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
JO McNamara, ER Andrechek, Y Wang, KD Viles, RE Rempel, E Gilboa, ...
Nature biotechnology 24 (8), 1005-1015, 2006
13242006
Aptamers: an emerging class of therapeutics
SM Nimjee, CP Rusconi, BA Sullenger
Annu. Rev. Med. 56 (1), 555-583, 2005
12042005
Notch promotes radioresistance of glioma stem cells
J Wang, TP Wakeman, JD Lathia, AB Hjelmeland, XF Wang, RR White, ...
Stem cells 28 (1), 17-28, 2010
7832010
In vivo activity of nuclease-resistant siRNAs
JM Layzer, AP McCaffrey, AK Tanner, ZAN Huang, MA Kay, BA Sullenger
Rna 10 (5), 766-771, 2004
7752004
RNA aptamers as reversible antagonists of coagulation factor IXa
CP Rusconi, E Scardino, J Layzer, GA Pitoc, TL Ortel, D Monroe, ...
Nature 419 (6902), 90-94, 2002
6782002
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
BA Sullenger, HF Gallardo, GE Ungers, E Gilboa
Cell 63 (3), 601-608, 1990
6181990
Emerging clinical applications of RNA
BA Sullenger, E Gilboa
Nature 418 (6894), 252-258, 2002
5742002
Aptamers as therapeutics
SM Nimjee, RR White, RC Becker, BA Sullenger
Annual review of pharmacology and toxicology 57 (1), 61-79, 2017
5292017
Antidote-mediated control of an anticoagulant aptamer in vivo
CP Rusconi, JD Roberts, GA Pitoc, SM Nimjee, RR White, G Quick Jr, ...
Nature biotechnology 22 (11), 1423-1428, 2004
4522004
Developing aptamers into therapeutics
RR White, BA Sullenger, CP Rusconi
The Journal of clinical investigation 106 (8), 929-934, 2000
3922000
Generation of species cross-reactive aptamers using “toggle” SELEX
R White, C Rusconi, E Scardino, A Wolberg, J Lawson, M Hoffman, ...
Molecular Therapy 4 (6), 567-573, 2001
3832001
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
JO McNamara, D Kolonias, F Pastor, RS Mittler, L Chen, PH Giangrande, ...
The Journal of clinical investigation 118 (1), 376-386, 2008
3632008
Ribozyme-mediated repair of defective mRNA by targeted trans-splicing
BA Sullenger, TR Cech
Nature 371 (6498), 619-622, 1994
3551994
In vivo selection of tumor-targeting RNA motifs
J Mi, Y Liu, ZN Rabbani, Z Yang, JH Urban, BA Sullenger, BM Clary
Nature chemical biology 6 (1), 22-24, 2010
3392010
Gene therapy progress and prospects: RNA aptamers
NS Que-Gewirth, BA Sullenger
Gene therapy 14 (4), 283-291, 2007
2862007
Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
NJ Ganson, TJ Povsic, BA Sullenger, JH Alexander, SL Zelenkofske, ...
Journal of Allergy and Clinical Immunology 137 (5), 1610-1613. e7, 2016
2762016
Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA
BA Sullenger, TR Cech
Science 262 (5139), 1566-1569, 1993
2761993
Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors
N Lan, RP Howrey, SW Lee, CA Smith, BA Sullenger
Science 280 (5369), 1593-1596, 1998
2741998
From the RNA world to the clinic
BA Sullenger, S Nair
Science 352 (6292), 1417-1420, 2016
2642016
Group II introns designed to insert into therapeutically relevant DNA target sites in human cells
H Guo, M Karberg, M Long, JP Jones III, B Sullenger, AM Lambowitz
science 289 (5478), 452-457, 2000
2642000
系统目前无法执行此操作,请稍后再试。
文章 1–20